Trial Information
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
Inclusion Criteria:
- Patients are eligible if they have histologically proven adenocarcinoma, are planning
to or currently undergoing treatment with an anti-EGFR (epidermal growth factor
receptor) therapy, and are 18 years of age or older.
Exclusion Criteria:
- None
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
George Albert Fisher M.D. Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
VAR0041
NCT ID:
NCT01137162
Start Date:
August 2008
Completion Date:
October 2011
Related Keywords:
- Anal, Colon, and Rectal Cancers
- Head and Neck Cancer
- Lung Cancer
- Colon Cancer
- Colonic Neoplasms
- Colorectal Neoplasms
- Colon/Rectal Cancer
- Colon/Rectal Cancer Colon Cancer
- Colon/Rectal Cancer Rectal Cancer
- Colon/Rectal Cancer Anal Cancer
- Head and Neck Cancers
- Head and Neck Cancers Lip
- Head and Neck Cancers Oral Cavity
- Head and Neck Cancers Nasopharynx
- Head and Neck Cancers Oropharynx
- Head and Neck Cancers Hypopharynx
- Head and Neck Cancers Larynx
- Head and Neck Cancers Trachea
- Lung Cancer Non-Small Cell Cancer (NSCLC)
- Lung Cancer Small Cell Lung Cancer (SCLC)
- Anus Neoplasms
- Neoplasms
- Colonic Neoplasms
- Rectal Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Head and Neck Neoplasms
- Lung Neoplasms
- Small Cell Lung Carcinoma
- Hypopharyngeal Neoplasms
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |